In one paragraphArticle in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
5 authors.
Allison E TammenDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR 97239, USA.ORCID 0000-0003-1333-4918 Jessie C PetersonVA Portland Health Care System, Portland, OR 97239, USA.
Funding
Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)UL1TR002369 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Cynthia D Morris, Christopher G. Slatore · 2017 to 2026
$78.4MLung Resident, MR1-Restricted T Cells: Association with Differential Outcomes Following Exposure to M. TuberculosisR01AI134790 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI LEWINSOHN, DAVID M., WALZL, GERHARD · 2018 to 2022
$3.3MProgram in Biomedical SciencesT32GM142619 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Jeffrey Wallace Tyner · 2021 to 2026
$3.2MInterdisciplinary Training in Microbial Pathogenesis and ImmunologyT32AI170496 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI Patrizia Caposio, Scott M Landfear · 2023 to 2026
$1.5MMR1-dependent presentation of Mycobacterium tuberculosis: a unique role for calcium signalingK08AI153359 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI KARAMOOZ, ELHAM · 2020 to 2024
$925kCalcium Signaling in MR1-Dependent Antigen PresentationR21AI151079 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI KARAMOOZ, ELHAM · 2020 to 2021
$424kThe impact of two-pore channel calcium signaling on MR1 antigen presentation of Mycobacterium tuberculosis metabolitesF31AI186352 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI Allison Tammen · 2025 to 2026
$100kBLRD VA I01 BX000533NCATS NIH HHS UL1 TR002369NIAID NIH HHS F31 AI186352NIAID NIH HHS K08 AI153359NIAID NIH HHS R01 AI134790NIAID NIH HHS R21 AI151079NIAID NIH HHS T32 AI170496NIGMS NIH HHS T32 GM142619
6 · The paper itselfAbstract
The immune system has developed specialized mechanisms to recognize intracellular pathogens such as
Indexed as
antigen presentationendosomal trafficking proteinsMAIT cellsMR1Mycobacterium tuberculosissyntaxins
Identifiers
PMID41573916
PMCPMC12822724
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390